-transparent.png){kind=logo}
The mechanism of inhibition of HIV-1 reverse transcriptase by three nonnucleoside inhibitors is described. Nevirapine, O-TIBO, and CI-TIBO each bind to a hydrophobic pocket in the enzyme-DNA complex close to the active site catalytic residues. Pre-steady-state kinetic analysis was used to establish the mechanism of inhibition by these noncompetitive inhibitors. Analysis of the pre-steady-state burst of DNA polymerization indicated that inhibitors blocked the chemical reaction, but did not interfere with nucleotide binding or the nucleotide-induced conformational change. Rather, in the presence of saturating concentrations of the inhibitors, the nucleoside triphosphate bound tightly (Kd, 100 nM), but nonproductively. The data suggest that an inhibitor combining the functionalities of a nonnucleoside inhibitor and a nucleotide analog could bind very tightly and specifically to reverse transcriptase and could be effective in the treatment of AIDS.
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
January 1996,
Biochemistry,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
December 1990,
Science (New York, N.Y.),
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
January 1996,
Methods in enzymology,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
November 2006,
PLoS pathogens,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
April 1995,
Nature structural biology,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
October 1997,
AIDS clinical care,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
June 2001,
Proceedings of the National Academy of Sciences of the United States of America,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
January 2006,
Current pharmaceutical design,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
June 2009,
Journal of medicinal chemistry,
R A Spence, and
W M Kati, and
K S Anderson, and
K A Johnson
January 2001,
Journal of clinical pharmacology,
